Intracellular Free Cash Flow vs Cash Per Share Analysis

ITCI Stock

USD 127.82 0.24 0.19%

Intracellular financial indicator trend analysis is infinitely more than just investigating Intracellular Th recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Intracellular Th is a good investment. Please check the relationship between Intracellular Free Cash Flow and its Cash Per Share accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Free Cash Flow vs Cash Per Share

Free Cash Flow vs Cash Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Intracellular Th Free Cash Flow account and Cash Per Share. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Intracellular's Free Cash Flow and Cash Per Share is -0.42. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Cash Per Share in the same time period over historical financial statements of Intracellular Th, assuming nothing else is changed. The correlation between historical values of Intracellular's Free Cash Flow and Cash Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Intracellular Th are associated (or correlated) with its Cash Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Per Share has no effect on the direction of Free Cash Flow i.e., Intracellular's Free Cash Flow and Cash Per Share go up and down completely randomly.

Correlation Coefficient

-0.42

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Cash Per Share

Most indicators from Intracellular's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intracellular Th current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

As of now, Intracellular's Selling General Administrative is increasing as compared to previous years. The Intracellular's current Tax Provision is estimated to increase to about 768 K, while Issuance Of Capital Stock is projected to decrease to 0.00.

	2022	2023	2024	2025 (projected)
Net Interest Income	7.4M	20.3M	23.4M	24.6M
Interest Income	7.4M	20.3M	23.4M	24.6M

Net Interest Income Interest Income

Intracellular fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Common Stock Shares Outstanding	Short Term Investments	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Retained Earnings Total Equity
Total Assets		0.8	0.83	0.92	0.75	0.77	0.82	-0.07	0.93	0.85	0.88	0.85	0.39	0.22	-0.64	1.0	0.63	0.69	-0.75	-0.89	0.78	0.65	0.92	0.78	0.88	-0.88
Other Current Liab	0.8		1.0	0.59	0.59	0.8	0.94	-0.23	0.9	0.39	0.94	0.98	0.48	0.15	-0.82	0.78	0.51	0.47	-0.87	-0.88	0.97	0.93	0.53	0.98	0.7	-0.85
Total Current Liabilities	0.83	1.0		0.62	0.64	0.84	0.95	-0.21	0.92	0.42	0.96	0.99	0.48	0.19	-0.81	0.8	0.55	0.5	-0.88	-0.91	0.96	0.91	0.56	0.97	0.73	-0.88
Total Stockholder Equity	0.92	0.59	0.62		0.77	0.63	0.64	0.0	0.8	0.95	0.71	0.65	0.38	0.21	-0.53	0.93	0.63	0.66	-0.63	-0.78	0.56	0.41	0.99	0.56	0.92	-0.8
Other Liab	0.75	0.59	0.64	0.77		0.82	0.67	0.18	0.8	0.69	0.63	0.69	0.41	0.35	-0.49	0.72	0.74	0.6	-0.64	-0.81	0.59	0.39	0.77	0.5	0.89	-0.83
Accounts Payable	0.77	0.8	0.84	0.63	0.82		0.82	0.13	0.88	0.51	0.79	0.84	0.33	0.26	-0.69	0.74	0.51	0.66	-0.79	-0.85	0.73	0.64	0.62	0.73	0.76	-0.84
Cash	0.82	0.94	0.95	0.64	0.67	0.82		-0.24	0.94	0.44	0.94	0.96	0.37	0.22	-0.82	0.79	0.62	0.62	-0.96	-0.92	0.89	0.78	0.6	0.9	0.77	-0.9
Other Assets	-0.07	-0.23	-0.21	0.0	0.18	0.13	-0.24		-0.13	0.12	-0.27	-0.22	-0.13	-0.12	0.05	-0.06	-0.23	0.07	0.21	0.17	-0.25	-0.22	0.05	-0.28	-0.03	0.15
Common Stock Shares Outstanding	0.93	0.9	0.92	0.8	0.8	0.88	0.94	-0.13		0.67	0.94	0.95	0.37	0.35	-0.71	0.91	0.7	0.68	-0.86	-0.96	0.87	0.72	0.78	0.85	0.89	-0.96
Short Term Investments	0.85	0.39	0.42	0.95	0.69	0.51	0.44	0.12	0.67		0.53	0.46	0.25	0.2	-0.31	0.87	0.54	0.64	-0.4	-0.62	0.39	0.23	0.98	0.35	0.8	-0.64
Other Current Assets	0.88	0.94	0.96	0.71	0.63	0.79	0.94	-0.27	0.94	0.53		0.96	0.5	0.28	-0.76	0.85	0.6	0.5	-0.89	-0.94	0.88	0.79	0.66	0.94	0.79	-0.93
Total Liab	0.85	0.98	0.99	0.65	0.69	0.84	0.96	-0.22	0.95	0.46	0.96		0.5	0.24	-0.77	0.82	0.64	0.52	-0.88	-0.94	0.96	0.87	0.6	0.95	0.78	-0.91
Common Stock	0.39	0.48	0.48	0.38	0.41	0.33	0.37	-0.13	0.37	0.25	0.5	0.5		0.18	-0.32	0.36	0.44	-0.13	-0.35	-0.51	0.47	0.4	0.31	0.48	0.49	-0.5
Property Plant Equipment	0.22	0.15	0.19	0.21	0.35	0.26	0.22	-0.12	0.35	0.2	0.28	0.24	0.18		0.06	0.19	0.52	0.21	-0.16	-0.4	0.19	-0.01	0.23	0.08	0.39	-0.42
Short Long Term Debt Total	-0.64	-0.82	-0.81	-0.53	-0.49	-0.69	-0.82	0.05	-0.71	-0.31	-0.76	-0.77	-0.32	0.06		-0.63	-0.18	-0.49	0.88	0.67	-0.72	-0.8	-0.45	-0.83	-0.59	0.64
Net Tangible Assets	1.0	0.78	0.8	0.93	0.72	0.74	0.79	-0.06	0.91	0.87	0.85	0.82	0.36	0.19	-0.63		0.59	0.7	-0.72	-0.85	0.76	0.64	0.92	0.75	0.86	-0.85
Property Plant And Equipment Net	0.63	0.51	0.55	0.63	0.74	0.51	0.62	-0.23	0.7	0.54	0.6	0.64	0.44	0.52	-0.18	0.59		0.43	-0.53	-0.78	0.59	0.27	0.63	0.42	0.79	-0.8
Current Deferred Revenue	0.69	0.47	0.5	0.66	0.6	0.66	0.62	0.07	0.68	0.64	0.5	0.52	-0.13	0.21	-0.49	0.7	0.43		-0.61	-0.57	0.45	0.35	0.7	0.4	0.62	-0.59
Net Debt	-0.75	-0.87	-0.88	-0.63	-0.64	-0.79	-0.96	0.21	-0.86	-0.4	-0.89	-0.88	-0.35	-0.16	0.88	-0.72	-0.53	-0.61		0.87	-0.77	-0.7	-0.57	-0.85	-0.75	0.86
Retained Earnings	-0.89	-0.88	-0.91	-0.78	-0.81	-0.85	-0.92	0.17	-0.96	-0.62	-0.94	-0.94	-0.51	-0.4	0.67	-0.85	-0.78	-0.57	0.87		-0.85	-0.67	-0.75	-0.83	-0.91	1.0
Non Current Assets Total	0.78	0.97	0.96	0.56	0.59	0.73	0.89	-0.25	0.87	0.39	0.88	0.96	0.47	0.19	-0.72	0.76	0.59	0.45	-0.77	-0.85		0.94	0.52	0.93	0.68	-0.81
Non Currrent Assets Other	0.65	0.93	0.91	0.41	0.39	0.64	0.78	-0.22	0.72	0.23	0.79	0.87	0.4	-0.01	-0.8	0.64	0.27	0.35	-0.7	-0.67	0.94		0.35	0.93	0.48	-0.62
Cash And Short Term Investments	0.92	0.53	0.56	0.99	0.77	0.62	0.6	0.05	0.78	0.98	0.66	0.6	0.31	0.23	-0.45	0.92	0.63	0.7	-0.57	-0.75	0.52	0.35		0.49	0.89	-0.76
Net Receivables	0.78	0.98	0.97	0.56	0.5	0.73	0.9	-0.28	0.85	0.35	0.94	0.95	0.48	0.08	-0.83	0.75	0.42	0.4	-0.85	-0.83	0.93	0.93	0.49		0.64	-0.8
Common Stock Total Equity	0.88	0.7	0.73	0.92	0.89	0.76	0.77	-0.03	0.89	0.8	0.79	0.78	0.49	0.39	-0.59	0.86	0.79	0.62	-0.75	-0.91	0.68	0.48	0.89	0.64		-0.92
Retained Earnings Total Equity	-0.88	-0.85	-0.88	-0.8	-0.83	-0.84	-0.9	0.15	-0.96	-0.64	-0.93	-0.91	-0.5	-0.42	0.64	-0.85	-0.8	-0.59	0.86	1.0	-0.81	-0.62	-0.76	-0.8	-0.92

Click cells to compare fundamentals

Intracellular Account Relationship Matchups

Intracellular fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	717.3M	489.9M	754.8M	728.3M	837.5M	879.4M
Other Current Liab	25.8M	37.9M	63.7M	108.5M	124.8M	131.0M
Total Current Liabilities	36.9M	53.4M	83.2M	123.5M	142.1M	149.2M
Total Stockholder Equity	656.9M	417.9M	656.1M	591.4M	680.1M	366.2M
Accounts Payable	5.5M	8.7M	10.4M	11.5M	13.2M	13.8M
Cash	60.0M	92.4M	148.6M	147.8M	169.9M	178.4M
Other Assets	608.1K	350.7K	86.1K	86K	98.9K	94.0K
Common Stock Shares Outstanding	70.4M	81.3M	94.0M	95.9M	110.3M	115.8M
Short Term Investments	597.4M	320.0M	443.3M	350.2M	402.7M	287.1M
Other Current Assets	15.6M	26.8M	46.9M	42.4M	48.8M	51.2M
Total Liab	60.5M	72.0M	98.7M	136.9M	157.4M	165.3M
Common Stock	8.0K	8.2K	9K	10K	11.5K	6.6K
Property Plant Equipment	2.3M	2.0M	22.6M	1.9M	2.2M	3.0M
Short Long Term Debt Total	29.1M	25.4M	20.0M	16.9M	15.2M	19.1M
Net Tangible Assets	195.0M	656.9M	417.9M	656.1M	754.5M	792.2M
Property Plant And Equipment Net	26.3M	22.6M	16.7M	14.6M	16.8M	9.6M
Net Debt	(30.9M)	(67.0M)	(128.6M)	(130.8M)	(117.7M)	(111.9M)
Retained Earnings	(937.1M)	(1.2B)	(1.5B)	(1.6B)	(1.5B)	(1.4B)
Non Current Assets Total	26.4M	22.6M	16.8M	60.5M	69.6M	73.0M
Cash And Short Term Investments	657.4M	412.3M	591.9M	497.9M	572.6M	388.7M
Net Receivables	10.8M	20.2M	75.2M	114.0M	131.1M	137.7M
Common Stock Total Equity	5.6K	8.0K	8.2K	9K	10.4K	5.5K
Retained Earnings Total Equity	(710.1M)	(937.1M)	(1.2B)	(1.5B)	(1.3B)	(1.3B)
Liabilities And Stockholders Equity	717.3M	489.9M	754.8M	728.3M	837.5M	443.0M
Non Current Liabilities Total	23.6M	18.7M	15.5M	13.3M	15.3M	10.0M
Capital Surpluse	905.0M	1.6B	1.6B	2.1B	2.5B	2.6B
Other Stockholder Equity	1.6B	1.6B	2.1B	2.2B	2.5B	2.7B
Property Plant And Equipment Gross	26.3M	1.8M	1.9M	14.6M	16.8M	17.6M
Total Current Assets	690.9M	467.3M	738.0M	667.8M	768.0M	428.9M
Accumulated Other Comprehensive Income	480.6K	(363.7K)	(4.2M)	104K	119.6K	125.6K
Net Invested Capital	656.9M	417.9M	656.1M	591.4M	680.1M	516.9M
Net Working Capital	654.1M	413.9M	654.7M	544.3M	625.9M	508.4M
Capital Stock	8.0K	8.2K	9K	10K	11.5K	8.5K
Capital Lease Obligations	29.1M	25.4M	20.0M	16.9M	15.2M	18.3M
Short Term Debt	5.5M	6.7M	9.1M	3.6M	4.2M	6.2M

Currently Active Assets on Macroaxis

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications
DIA	SPDR Dow Jones
SPY	SPDR SP 500

When determining whether Intracellular Th offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intracellular's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intracellular Th Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intracellular Th Stock:

How To Invest In Intracellular

Details

Is Intracellular Stock a good investment?

Details

What is Intracellular's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.87)

Revenue Per Share

6.096

Quarterly Revenue Growth

0.39

Return On Assets

(0.07)

Return On Equity

(0.1)

The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Intracellular Free Cash Flow vs Cash Per Share Analysis

Free Cash Flow vs Cash Per Share

Free Cash Flow vs Cash Per Share Correlation Analysis

Correlation Coefficient

Free Cash Flow

Cash Per Share

Intracellular fundamental ratios Correlations

Intracellular Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Intracellular fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Retained Earnings Total Equity	+ 1.0	Retained Earnings
Total Liab	+ 0.99	Total Current Liabilities
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Total Liab	+ 0.98	Other Current Liab

Retained Earnings Total Equity	- 0.96	Common Stock Shares Outstanding
Retained Earnings	- 0.96	Common Stock Shares Outstanding
Net Debt	- 0.96	Cash
Retained Earnings	- 0.94	Total Liab
Retained Earnings	- 0.94	Other Current Assets
Retained Earnings Total Equity	- 0.93	Other Current Assets